| Date | Title | Description |
| 13.01.2026 | At-home STD tests offer new options for screening and treatment | Getting your Trinity Audio player ready...
By MATTHEW PERRONE, AP Health Writer
WASHINGTON (AP) — New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend that experts hope w... |
| 19.11.2025 | Manta Cares Launches to Redesign the Cancer Experience for Patients and Caregivers | Award winning company partners with three of the top 15 pharmaceutical companies, to scale its patient-first digital platform
SAN FRANCISCO, Nov. 19, 2025 /PRNewswire-PRWeb/ -- Manta Cares, an award winning digital health company transformi... |
| 23.06.2025 | The Future of Health: At-Home Diagnostics and the Rise of Gut Sodas | In the evolving landscape of health and wellness, two distinct trends are emerging: at-home diagnostics and gut sodas. Each represents a shift in how we approach health, convenience, and self-care. Both are driven by innovation and a desire... |
| 23.06.2025 | Visby Medical: Up To $65 Million Raised For At-Home Polymerase Chain Reaction Diagnostics | Visby Medical, a leader in rapid, at-home polymerase chain reaction (PCR) diagnostics, announced it has raised approximately $55 million, with the potential to reach $65 million, in its latest financing round led by Catalio Capital Manageme... |
| 19.06.2025 | Visby Medical Raises Up To $65M in Funding | Visby Medical, a San Jose, CA-based at-home polymerase chain reaction (PCR) diagnostics company, raised approximately $55M in funding.
The round was led by Catalio Capital Management, with participation from existing investors including ND ... |
| 19.06.2025 | Visby Medical raises up to $65M to commercialize home STI test | Photo: Halfpoint Images/Getty Images
At-home testing company Visby Medical announced that it has received approximately $55 million in funding, with the potential to raise an additional $10 million.
Catalio Capital Management led the round ... |
| 22.11.2022 | Why doesn’t the U.S. have at-home flu tests? | Flu season is underway. RSV is putting record numbers of children in hospitals. And health professionals are gearing up for another Covid winter.
With so many potential viruses in play, it would be helpful if Americans had a way to distingu... |
| 30.06.2022 | Visby Medical tests positive for a Series E extension at $1B+ valuation | Medical diagnostics company Visby Medical raised $100 million in a Series E round earlier this year. Today, the company told me it extended that round by an additional $35 million at the same valuation as the rest of the round. This financi... |
| 29.06.2022 | Visby Medical Raises Additional $35M; Brings Series E to Over $135M | Visby Medical, a San Jose, CA-based medical diagnostic company, expanded its Series E financing to include an additional $35m for a total of over $135m raised in the round.
The additional investment was led by Lightrock, who joined existing... |
| 29.06.2022 | Visby Medical raises $135M in expanded Series E | Visby Medical announced today that it added $35 million to an expanded, oversubscribed Series E financing round.
San Jose, California–based Visby plans to use the additional investment, which brings its Series E to $135 million in total, to... |
| 29.06.2022 | Visby Medical's VC round swells to $135M to add new tests to hand-held PCR platform | Even after gobbling up an overstuffed funding round earlier this year, Visby Medical seems to have saved room for dessert. The cherry on top of that $100 million megaround is an extra dollop of venture capital that brings its final total to... |
| 05.03.2022 | Visby Medical Raises $100M in Series E |
SAN JOSE, CA, Visby Medical, a medical diagnostic company, has raised over $100 million in its Series E financing round led by Ping An Voyager Partners.
>> Click here for more funding data on Visby Medical
>> To export Visby... |
| 02.03.2022 | Visby Medical Raises Over $100M in Series E Financing | Visby Medical, a San Jose, CA-based medical diagnostic company, raised over $100m in Series E financing round.
The round was led by Ping An Voyager Partners, joined by the Healthcare of Ontario Pension Plan (HOOPP), with participation from ... |
| 13.09.2021 | FDA Grants Emergency Use Authorization for Visby Medical's COVID-19 RT-PCR Test for Pooled Samples | |
| 20.05.2021 | Molecular diagnostics company Atonarp scores $50M in Series D funding | Photo by Cryptographer/Shutterstock |
| 18.03.2021 | Ibex’s Daphna Laifenfeld On AI-Powered Cancer Diagnostics, Company Raising $38 Million In Series B Funding And The Future Of Personalized Medicine | Daphna Laifenfeld, Ibex’s Chief Scientific OfficerIbex Medical Analitycs |
| 20.12.2020 | Bringing Routine Covid-19 Testing Into The Home | Detect rapid molecular isothermal systemDetect |
| 13.10.2020 | Visby Medical's Personal PCR Receives Funding from National Institute of Health, RADx Program | |
| 21.09.2020 | Visby Medical's Personal PCR Device Receives FDA Emergency Use Authorization For Moderate-Complexity Lab Environments | |
| 19.12.2019 | Molecular Diagnostics Company ArcherDX Raises $55 Million | ArcherDX, a molecular diagnostics company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, announced it raised $55 million
ArcherDX — a molecular diagnostics company dedicated to ... |
| 31.10.2019 | Mercia-backed diagnostics company raises £12.3m | Sense Biodetection, the Cambridge-based diagnostics company which is backed by Mercia, has raised £12.3m to develop a new range of tests, initially targeting infectious diseases like flu. |
| 29.05.2018 | Molecular Diagnostics Company Mobidiag Raises €1.5M Loan | Following the announcement of a €4m funding, Mobidiag Ltd., an Espoo, Finland-based molecular diagnostics company, received a €1.5m loan from Business Finland (formerly Tekes).
The company will use the funds for the development of a sepsis ... |
| 16.04.2013 | Women’s health cancer diagnostics company DySIS Medical raises $9.7M | Women’s health company DySIS Medical touted a $11.3 million (£7.4 million) fundraising round in support of its diagnostic devices.
The Scotland-based medical device maker hopes to expand market reach in Europe and the U.S. for its DySIS col... |
| 08.06.2007 | Biomarker diagnostics company Singulex raises $19M | See our story here at VentureBeat LifeSciences.
VentureBeat VentureBeat's mission is to be a digital townsquare for technical decision makers to gain knowledge about transformative technology and transact. Our site delivers essential inform... |
| - | Visby Medical Recently Raised Over $100 Million In Series E | Visby Medical recently announced that it raised over $100 million in Series E funding. These are the details.
Visby Medical — a leading medical diagnostic company — recently announced that it has raised over $100 million in its Series E fin... |
| - | Variantyx: Molecular Diagnostics Company Closes $36 Million In Funding | Variantyx, a molecular diagnostics leader, announced that it had secured an additional $36 million in funding from its portfolio of investors, which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners, and Bosch Ventur... |
| - | Visby Medical | “Visby Medical is a medical diagnostics company with portable PCR testing technology for both clinical and mobile laboratory settings.” |
| - | Cancer diagnostics company using genomics analysis raising $1.3 million | Company name: RedPath Integrated Pathology.
Industry: Cancer diagnostics.
Location: Pittsburgh, Pennsylvania.
Solution/product: The biotechnology company uses genomics analysis to detect cancer. PathFinder TG uses molecular analysis of muta... |
